XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 80 filers reported holding XENON PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,362,744 | -6.3% | 69,167 | +5.6% | 0.00% | – |
| Q2 2023 | $2,521,097 | +15.5% | 65,483 | +7.3% | 0.00% | – |
| Q1 2023 | $2,183,298 | -8.0% | 61,003 | +1.3% | 0.00% | – |
| Q4 2022 | $2,374,356 | +29.3% | 60,217 | +18.3% | 0.00% | – |
| Q3 2022 | $1,837,000 | +25.8% | 50,891 | +6.0% | 0.00% | – |
| Q2 2022 | $1,460,000 | +6.7% | 47,996 | +7.2% | 0.00% | – |
| Q1 2022 | $1,368,000 | -13.4% | 44,776 | -11.5% | 0.00% | – |
| Q4 2021 | $1,580,000 | +172.9% | 50,596 | +33.7% | 0.00% | – |
| Q3 2021 | $579,000 | -30.4% | 37,850 | -15.4% | 0.00% | – |
| Q2 2021 | $832,000 | -8.0% | 44,721 | -11.6% | 0.00% | – |
| Q1 2021 | $904,000 | +26.1% | 50,562 | +8.5% | 0.00% | – |
| Q4 2020 | $717,000 | +3.9% | 46,622 | -25.2% | 0.00% | – |
| Q3 2020 | $690,000 | -10.6% | 62,353 | +1.2% | 0.00% | – |
| Q2 2020 | $772,000 | +16.3% | 61,635 | +5.2% | 0.00% | – |
| Q1 2020 | $664,000 | +14.7% | 58,599 | +32.7% | 0.00% | – |
| Q4 2019 | $579,000 | +70.8% | 44,143 | +17.3% | 0.00% | – |
| Q3 2019 | $339,000 | -8.6% | 37,636 | 0.0% | 0.00% | – |
| Q2 2019 | $371,000 | +50.8% | 37,636 | +55.5% | 0.00% | – |
| Q1 2019 | $246,000 | +219.5% | 24,202 | +97.6% | 0.00% | – |
| Q4 2018 | $77,000 | -43.4% | 12,246 | +18.9% | 0.00% | – |
| Q3 2018 | $136,000 | – | 10,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |